GLP-1 receptor agonists such as Saxenda and Wegovy work, with clinical trial evidence behind them roughly 6% and 16% body weight reduction respectively over 68-week trials
As of this writing, neither cagrilintide monotherapy nor the CagriSema combination is approved for any indication anywhere, and it may not be prescribed or sold for human use
If it has solid ratings and the price isnt too good to be true, youll have a good idea if its worth trying
Raigani, S
Furthermore, among those already with a SUD, GLP-1s appeared to lower hospitalizations, overdoses, and death, GLP-1 receptor agonists are not replacements for current medication treatments for AUDbut may soon become important additions
In summary, vitamin B12 and B complex injections each provide their distinct benefits, but they are not interchangeable